- ValGenesis Inc. is the market leader in digital validation lifecycle management, providing solutions that streamline compliance and quality processes for life sciences companies.
- In April 2026, ValGenesis launched the next generation of its VALTM platform, incorporating governed AI to enhance validation activities, and secured $16 million in strategic financing to accelerate global expansion and innovation.
- ValGenesis formed a strategic partnership with Westbourne in April 2026 to enhance digital validation services and has been selected by a leading global vaccine manufacturer to digitalize equipment qualification and computer system validation.
- ValGenesis targets life sciences companies facing stringent regulatory requirements, offering solutions that significantly reduce validation time and costs, making it a compelling choice for organizations looking to improve compliance and operational efficiency.
ValGenesis employs a diverse workforce across 12 departments, with a total headcount of 492. The Operations department is the largest, comprising 24 employees, followed closely by Information Technology with 15 and Engineering with 10. This distribution indicates a strong emphasis on operational efficiency and technical expertise, while maintaining a balanced presence in sales, human resources, and marketing.
The company's workforce is distributed across 17 locations, with a significant concentration in the 'Other' category, which accounts for 76 employees. Among the top locations, Fremont, CA, has 2 employees, while New Hope, PA, Broomfield, CO, Fayville, MA, Sunnyvale, CA, Boston, MA, Santa Clara, CA, Houston, TX, and Denver, CO each have 1 employee. This suggests a predominantly remote or distributed workforce, with a limited number of employees concentrated in specific geographic areas.
